Drug Shortage Report for JAMP OLMESARTAN

Last updated on 2022-12-09 History
Report ID 96211
Drug Identification Number 02461641
Brand name JAMP-OLMESARTAN
Common or Proper name Olmesartan
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) OLMESARTAN MEDOXOMIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-07
Estimated end date 2023-06-30
Actual end date 2022-12-01
Shortage status Resolved
Updated date 2022-12-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2022-12-09 French Compare
v14 2022-12-09 English Compare
v13 2022-10-07 French Compare
v12 2022-10-07 English Compare
v11 2021-04-07 French Compare
v10 2021-04-07 English Compare
v9 2020-06-19 French Compare
v8 2020-06-19 English Compare
v7 2020-02-18 French Compare
v6 2020-02-18 English Compare
v5 2019-12-10 French Compare
v4 2019-12-10 English Compare
v3 2019-10-11 French Compare
v2 2019-10-11 English Compare
v1 2019-10-11 English Compare

Showing 1 to 15 of 15